Modulation of brain catecholamine absorbing proteins by dopaminergic agents.

[1]  G. Sedvall,et al.  Dopamine receptors in schizophrenia , 1996, The Lancet.

[2]  B. McCarry,et al.  Covalent Affinity Labeling of Brain Catecholamine‐Absorbing Proteins Using a High‐Specific‐Activity Substituted Tetrahydronaphthalene , 1995, Journal of neurochemistry.

[3]  J. Cadet.  Free radicals and neurodegeneration , 1994, Trends in Neurosciences.

[4]  P. Jenner.  Oxidative damage in neurodegenerative disease , 1994, The Lancet.

[5]  M. Zigmond,et al.  Identification of Catechol‐Protein Conjugates in Neostriatal Slices Incubated with [3H]Dopamine: Impact of Ascorbic Acid and Glutathione , 1994, Journal of neurochemistry.

[6]  C. Marsden,et al.  Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study , 1994, Movement disorders : official journal of the Movement Disorder Society.

[7]  H. Niznik,et al.  Dopamine receptors and transporters : pharmacology, structure, and function , 1994 .

[8]  C. Olanow.  A radical hypothesis for neurodegeneration , 1993, Trends in Neurosciences.

[9]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[10]  P. Riederer,et al.  The possible role of iron in the etiopathology of parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[11]  H. Niznik,et al.  Dopamine receptor genes: new tools for molecular psychiatry. , 1992, Journal of psychiatry & neuroscience : JPN.

[12]  C. Olanow,et al.  An introduction to the free radical hypothesis in Parkinson's disease , 1992, Annals of neurology.

[13]  J. Thorner,et al.  Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.

[14]  E. Abercrombie,et al.  Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats , 1990, Brain Research.

[15]  F. Hefti,et al.  Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture , 1990, Journal of neuroscience research.

[16]  R. Baldessarini,et al.  Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues. , 1990, Journal of medicinal chemistry.

[17]  P. Hartman,et al.  Production and specificity of monoclonal antibodies and polyclonal antibodies to Escherichia coli. , 1987, The Journal of applied bacteriology.

[18]  H. Szechtman.  Effects of pretreatment with naloxone on behaviours induced by a small dose of apomorphine , 1986, Pharmacology Biochemistry and Behavior.

[19]  T. Kato,et al.  Tyrosinase-catalyzed binding of 3,4-dihydroxyphenylalanine with proteins through the sulfhydryl group. , 1986, Biochimica et biophysica acta.

[20]  M. Geyer,et al.  Indirect effects of apomorphine on serotoninergic neurons in rats , 1984, Neuroscience.

[21]  W. Bonner.  Fluorography for the detection of radioactivity in gels. , 1984, Methods in enzymology.

[22]  G. Cohen.  The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. , 1983, Journal of neural transmission. Supplementum.

[23]  P. Seeman.  Brain dopamine receptors. , 1980, Pharmacological reviews.

[24]  Cools Ar.  Rapid development of hypersensitivity and hyposensitivity to apomorphine and haloperidol: role of norepinephrine receptor mechanisms in CNS. , 1980 .

[25]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Yasunobu,et al.  Bovine liver monoamine oxidase. A modified purification procedure and preliminary evidence for two subunits and one FAD. , 1978, Archives of biochemistry and biophysics.

[27]  R. Hoeldtke,et al.  Bovine adrenal tyrosine hydroxylase: purification and properties. , 1977, The Journal of biological chemistry.

[28]  J. Daly,et al.  Oxygen-dependent reaction of 6-hydroxydopamine, 5,6-dihydroxytryptamine, and related compounds with proteins in vitro: a model for cytotoxicity. , 1976, Molecular pharmacology.

[29]  S. Lal,et al.  Effect of catechol‐O‐methyltransferase inhibitors on brain apomorphine concentrations and stereotyped behaviour in the rat , 1975, The Journal of pharmacy and pharmacology.

[30]  M. Scheulen,et al.  Irreversible binding of DOPA and dopamine metabolites to protein by rat liver microsomes. , 1975, Biochemical and biophysical research communications.

[31]  M. Maguire,et al.  The Reaction of [3H]Norepinephrine with Particulate Fractions of Cells Responsive to Catecholamines , 1974 .

[32]  H. Thoenen,et al.  Model experiments on the molecular mechanism of action of 6-hydroxydopamine. , 1971, Molecular pharmacology.

[33]  G. Jonsson.  Quantitation of fluorescence of biogenic monoamines demonstrated with the formaldehyde flourescence method. , 1971, Progress in histochemistry and cytochemistry.

[34]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[35]  J. Phillis.  The pharmacology of synapses , 1970 .

[36]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[37]  J. Axelrod.  O-methylation of epinephrine and other catechols in vitro and in vivo. , 1957 .

[38]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.